Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic acid for prevention of cisplatin-induced hearing loss
NCT00477607Phase 3Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in ototoxicity, sponsored by United States Department of Veterans Affairs. Started Oct 2007; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT00477607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477607.